PURPOSE: To determine whether parity is associated with increased risk of cardiovascular disease (CVD) after accounting for perinatal complications. METHODS: CVD prevalence, number of births, and a history of preeclampsia, term low birth weight, preterm or stillbirth were evaluated among 540 women (mean age, 80 years; 47% black) enrolled in the Pittsburgh, PA site of the Health, Aging and Body Composition Study. Biomarkers were measured and CVD status was determined by self-report and hospital records. RESULTS: Nulliparous women (n = 89) had lower CVD prevalence compared with parous women (18.0% vs. 30.2%). Parous women without perinatal complications of interest (n = 321) had higher statin use compared with nulliparas, a trend accompanied by lower high-density lipoprotein (HDL) and higher triglycerides among women with perinatal complications (n = 130). After adjustment, parous women with no complicated births had a 1.95-fold (95% confidence interval [CI], 1.03-3.7) higher CVD prevalence compared to nulliparas. Among women with one or more pregnancy complications, CVD prevalence was 2.67 times (CI, 1.34-5.33) higher. Women with five or more births had the highest CVD prevalence (odds ratio [OR], 2.60; CI, 1.17-5.76) that was attenuated to 2.27 (1.00-5.15) after adjustment for complications of interest. CONCLUSIONS: History of pregnancy complications and higher statin use accounted for some but not all of the excess CVD prevalence among older parous women.
PURPOSE: To determine whether parity is associated with increased risk of cardiovascular disease (CVD) after accounting for perinatal complications. METHODS: CVD prevalence, number of births, and a history of preeclampsia, term low birth weight, preterm or stillbirth were evaluated among 540 women (mean age, 80 years; 47% black) enrolled in the Pittsburgh, PA site of the Health, Aging and Body Composition Study. Biomarkers were measured and CVD status was determined by self-report and hospital records. RESULTS: Nulliparous women (n = 89) had lower CVD prevalence compared with parous women (18.0% vs. 30.2%). Parous women without perinatal complications of interest (n = 321) had higher statin use compared with nulliparas, a trend accompanied by lower high-density lipoprotein (HDL) and higher triglycerides among women with perinatal complications (n = 130). After adjustment, parous women with no complicated births had a 1.95-fold (95% confidence interval [CI], 1.03-3.7) higher CVD prevalence compared to nulliparas. Among women with one or more pregnancy complications, CVD prevalence was 2.67 times (CI, 1.34-5.33) higher. Women with five or more births had the highest CVD prevalence (odds ratio [OR], 2.60; CI, 1.17-5.76) that was attenuated to 2.27 (1.00-5.15) after adjustment for complications of interest. CONCLUSIONS: History of pregnancy complications and higher statin use accounted for some but not all of the excess CVD prevalence among older parous women.
Authors: C A Tomeo; J W Rich-Edwards; K B Michels; C S Berkey; D J Hunter; A L Frazier; W C Willett; S L Buka Journal: Epidemiology Date: 1999-11 Impact factor: 4.822
Authors: K Sutton-Tyrrell; A Newman; E M Simonsick; R Havlik; M Pahor; E Lakatta; H Spurgeon; P Vaitkevicius Journal: Hypertension Date: 2001-09 Impact factor: 10.190
Authors: Yamnia I Cortés; Nisha Parikh; Matthew A Allison; Michael H Criqui; Natalie Suder; Emma Barinas-Mitchell; Christina L Wassel Journal: J Womens Health (Larchmt) Date: 2018-12-01 Impact factor: 2.681
Authors: Dhananjay Vaidya; Wendy L Bennett; Christopher T Sibley; Joseph F Polak; David M Herrington; Pamela Ouyang Journal: Hypertension Date: 2014-08 Impact factor: 10.190
Authors: Tianyi Huang; Amy L Shafrir; A Heather Eliassen; Kathryn M Rexrode; Shelley S Tworoger Journal: Am J Epidemiol Date: 2020-07-01 Impact factor: 4.897
Authors: Marni B Jacobs; Donna Kritz-Silverstein; Deborah L Wingard; Elizabeth Barrett-Connor Journal: Fertil Steril Date: 2011-11-28 Impact factor: 7.329
Authors: Monika Sanghavi; Jacquelyn Kulinski; Colby R Ayers; David Nelson; Robert Stewart; Nisha Parikh; James A de Lemos; Amit Khera Journal: Eur J Prev Cardiol Date: 2015-02-17 Impact factor: 7.804
Authors: Hend Mansoor; Islam Y Elgendy; Renessa S Williams; Verlin W Joseph; Young-Rock Hong; Arch G Mainous Journal: Clin Cardiol Date: 2018-08-17 Impact factor: 2.882